Drugs is the largest component in the financing of health that reaches approximately 70%. Therefore,
treatment with the drug is a strategic effort in the control of health care financing in Indonesia. To provide an alternative drug to the public with quality assured and affordable prices, the government since 1989 has launched the Generic Drug program.
The purpose of the program is to carry out community access, especially the middle to lower income.
To Tiu, Minister of Health has issued Decree No. 085 / Menkes / SK / 89 concerning the obligation to prescribe and / or use of generic drugs in public health facilities.
In fact, the use of generic drugs has not been as expected.
The condition is still by weight for health care consumers have almost no bargaining power as well as other consumers.
consumers who need health care is dependent upon physician.
To overcome this, the government through the Minister of Health No.HK .02.02 / Menkes / 068/1/2010 dated January 14, 2010 instructed all government health facilities shall prescribe and / or use drugs generic.
Not that sajja, in order to assure the availability and equitable distribution of medicine, the Ministry of Health through Kepmenkes No.HK.03.01 / Menkes / 1461/2010 dated January 27, 2010 has made assessment / review of generic drug prices that have been previously defined.
in addition, that the use of generic drugs to be effective Menkes set Decree No.
HK.03.01 / Menkes / 159/1/2010 dated January 28, 2010 on guidelines for supervision over the use of generic drugs in government health services.
However, the use of generic drugs in the community has not been as expected.
Therefore, it is time the community is encouraged to use their rights as stipulated in Law No. 8 of 1999 on Consumer Protection, which is using its right to obtain correct information, clearly and honestly, the right to vote and the right to be heard.
Why
generics?
Internationally, the only remedy is divided into two, namely patented drugs and generic drugs.
Drug patent is the newly discovered drugs berdasrkan research and owns the patent term depending on the type of medicine.
According to Law No.14 of 2001, the period of validity of patent in Indonesia is 20 years.
for 20 years, the pharmaceutical company has exclusive rights to produce and market.
other companies should not be manufacture and market similar drugs if you do not have an agreement with the patent owner.
Once the drug patent expiration of the patent, then called generic drugs are drugs with names efficacious substance,
generic drugs in Indonesia are known in two kinds: ie 1).
the generic drugs branded, namely drugs generic given the trade name or names of the industry.
the generic drugs branded generics no difference in nutritious substances, the only difference being the name.
the generic drugs, generally called generic drugs only, while branded generic drug is often understood as a patent medicine.
And this is the assumption is wrong, let alone the notion of patented drugs is often translated as a very strong drug that can be misleading.
翻訳されて、しばらくお待ちください..